Summary & Overview
CPT 31661: Bronchoscopic Radiofrequency Airway Ablation
CPT code 31661 denotes a bronchoscopic radiofrequency ablation procedure in which a radiofrequency catheter is introduced into the bronchus to treat airway smooth muscle across two or more lung lobes. This intervention is clinically relevant as an advanced endoscopic therapy for patients with severe, treatment-resistant asthma and other airway disorders where targeted reduction of airway smooth muscle may improve symptoms and reduce exacerbations. Nationally, the code represents a specialized, resource-intensive procedure typically performed in hospital outpatient departments and ambulatory surgical centers.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for the procedure, typical settings of care, common billing considerations, and what to expect in payer coverage landscapes. The report covers benchmarking elements, relevant coding guidance, and recent policy updates that affect authorization and reimbursement practices for advanced bronchoscopic therapies. Where input data is incomplete, the publication notes that specific payer policy details, associated taxonomies, and ICD-10 linkage are not available in the input.
Billing Code Overview
CPT code 31661 describes a bronchoscopic procedure in which a radiofrequency catheter is introduced into the bronchus under bronchoscopic visualization to deliver radiofrequency energy to airway smooth muscle. The procedure is performed on any two or more lobes of the lungs and is used in patients with conditions such as severe asthma.
-
Service type: Bronchoscopic endoscopic therapeutic procedure involving radiofrequency ablation of airway smooth muscle.
-
Typical site of service: Hospital outpatient department or ambulatory surgical center where advanced bronchoscopic therapeutic interventions are performed.
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient with severe, persistent asthma refractory to maximal medical therapy (inhaled corticosteroids, long-acting bronchodilators, leukotriene modifiers, and biologic therapy) is referred to interventional pulmonology for bronchoscopic bronchial thermoplasty. The patient undergoes pre-procedure evaluation including pulmonary function testing, chest imaging, allergy/atopy assessment, and anesthesia risk assessment. On the day of service, the patient is brought to the bronchoscopy suite or ambulatory surgery center; procedural sedation or general anesthesia is administered per anesthesia and interventional pulmonology protocols. Under bronchoscopic visualization, a radiofrequency catheter is introduced into segmental bronchi of two or more lobes; controlled radiofrequency energy is applied to reduce airway smooth muscle mass. The patient is monitored post-procedure in recovery for respiratory status, given bronchodilator therapy and short course systemic steroids as indicated, and discharged home same day or admitted for overnight observation based on clinical status and institutional protocols. Follow-up visits document response to therapy, complications, and need for additional lobar treatment in subsequent sessions as per the treatment plan.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | CMS - Office or Other Outpatient Service by Same Physician or Other Qualified Health Care Professional During Postoperative Period | Use when the service is performed during the global postoperative period and represents a return to the outpatient setting for evaluation or treatment related to the procedure when applicable. |